CEACAM5 and colorectal carcinoma: Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) are commonly used biomarkers in everyday clinical practice for the detection and monitoring of CRC, but due to insufficient sensitivity and low organ specificity there is a need for more reliable biomarkers [5, 6].